MLB Suspension of Jurickson Profar
Major League Baseball (MLB) is poised to suspend Atlanta Braves outfielder Jurickson Profar for an entire season following reports of a potential second violation of its performance-enhancing drugs policy. According to an anonymous source who talked to the Associated Press, the ongoing grievance process, first highlighted by ESPN, has not yet been formally announced. Profar plans to contest the impending suspension through the players’ association, aiming for an appeal to be heard by independent arbitrator Martin F. Scheinman.
Previous Disciplinary Action
This situation arises as Profar has already faced disciplinary action; in March 2023, he received an 80-game ban after testing positive for Chorionic Gonadotropin (hCG), a hormone linked to testosterone production. In the wake of that incident, Profar expressed regret, stating:
“I would never willingly take a banned substance, but I take full responsibility and accept MLB’s decision.”
Performance and Future Prospects
In 2024, Profar earned an All-Star selection, bouncing back from suspension to hit 14 home runs and achieve a .245 batting average before further elevating his performance the following season with a .280 batting average, 24 home runs, and 85 RBIs. He was confirmed to have undergone sports hernia surgery during the previous offseason, which had a recovery period of approximately six weeks. During the early spring training matches this year, Profar played in four games, managing three hits and three RBIs in ten at-bats. Additionally, he was expected to represent the Netherlands in the upcoming World Baseball Classic.
Impact of Suspension
If the 162-game suspension is implemented, it would render Profar ineligible for postseason play and result in a loss of his projected $15 million salary for the current year, part of a lucrative $42 million contract spanning three years. He would also be following in the footsteps of several players who have faced long suspensions for similar offenses, including notable figures such as Jenrry Mejia and Robinson Canó.
Braves’ Roster Adjustments
The Braves, currently adjusting their roster with Mike Yastrzemski’s recent signing, are eyeing potential replacements for Profar’s position as designated hitter. Notably, Drake Baldwin, the 2025 NL Rookie of the Year, may step into this role when not catching, especially with other outfielders like Michael Harris and Ronald Acuña Jr.. Since Ha-seong Kim will miss time with a finger injury, Mauricio Dubon is anticipated to fill in at shortstop during this transitional period.
Conclusion
The potential absence of Profar opens a window for Dominic Smith, who recently joined the team on a minor league contract. As the Braves navigate this challenge, they must adjust their line-up while hoping for a positive resolution to Profar’s situation. This development in Profar’s career adds to an increasing list of athletes facing sanctions for failed drug tests, painting a concerning picture within the league regarding adherence to drug policies.
AP Sports Writer Charles Odom contributed to this report.
